David Miklos, MD, Stanford University

Articles

Diffuse Large B-Cell Lymphoma Overview: An Aggressive Heterogenous Disease

December 23rd 2021

A panel of oncologists talks about diffuse large B-cell lymphoma, what patient and disease factors one should take into account when thinking about DLBCL.

Ongoing Issues in CAR T-Cell Therapy and Lymphoma

July 2nd 2020

Developing CAR T-Cell Trials

July 2nd 2020

Allogenic CAR T-Cell Therapy in Lymphoma

July 2nd 2020

CAR T-Cell Therapy’s Future for Lymphoma

July 2nd 2020

CAR T Cells and Lymphoma Adverse Events

July 2nd 2020

LBCL Therapy: The Right Therapy

July 2nd 2020

R/R NHL: Candidate Identification and Referrals

July 2nd 2020

CAR T-Cell Therapy for Follicular Lymphoma

July 2nd 2020

ZUMA-2 Trial Overview: Mantle Cell Lymphoma Impact

July 2nd 2020

LDH and ECOG Performance Tests

July 2nd 2020

Liso-cel Therapy in R/R Large B-Cell Lymphoma

July 2nd 2020

The Importance of Antigen Loss in R/R Disease

July 2nd 2020

R/R Large B-Cell Therapy in Managing Various Lymphomas

July 2nd 2020

CAR T-Cell Therapy in Managing Various Lymphomas

July 2nd 2020

Rationale for Further Development of CAR T-Cell therapy

July 2nd 2020

Dr. Miklos on Development Process for KTE-X19 in MCL

May 20th 2020

David Miklos, MD, discusses the process of developing KTE-X19 and the ZUMA-2 trial in mantle cell lymphoma.

Dr. Miklos on Alternative Options to KTE-X19 in MCL, While Awaiting FDA Decision

May 7th 2020

David Miklos, MD, discusses alternative options to the investigational CAR T-cell therapy KTE-X19 for patients with relapsed/refractory mantle cell lymphoma, while awaiting a regulatory decision from the FDA.

Dr. Miklos on Anticipated Sequencing Challenges With KTE-X19 in MCL

May 4th 2020

David Miklos, MD, discusses anticipated sequencing challenges with the investigational CAR T-cell therapy KTE-X19 in mantle cell lymphoma.

Dr. Miklos on the Safety Profile of KTE-X19 in MCL

April 2nd 2020

David Miklos, MD, discusses the safety profile of KTE-X19 in mantle cell lymphoma.